Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells

Despite the high prevalence of histological Benign Prostatic Hypeplasia (BPH) in elderly men, little is known regarding the molecular mechanisms and networks underlying the development and progression of the disease. Here, we explored the effects of a phytotherapeutic agent, Lipidosterolic extract o...

Full description

Bibliographic Details
Main Authors: Stéphane Terry, Alexandre de la Taille, Aurélien Descazeaud, Francis Vacherot, Virginie Fasolo, Nanor Sirab, Grégoire Robert
Format: Article
Language:English
Published: MDPI AG 2013-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/14/7/14301
id doaj-48ce0ad3557741269e172fc6d0c23380
record_format Article
spelling doaj-48ce0ad3557741269e172fc6d0c233802020-11-25T01:57:22ZengMDPI AGInternational Journal of Molecular Sciences1422-00672013-07-01147143011432010.3390/ijms140714301Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal CellsStéphane TerryAlexandre de la TailleAurélien DescazeaudFrancis VacherotVirginie FasoloNanor SirabGrégoire RobertDespite the high prevalence of histological Benign Prostatic Hypeplasia (BPH) in elderly men, little is known regarding the molecular mechanisms and networks underlying the development and progression of the disease. Here, we explored the effects of a phytotherapeutic agent, Lipidosterolic extract of the dwarf palm plant Serenoa repens (LSESr), on the mRNA gene expression profiles of two representative models of BPH, BPH1 cell line and primary stromal cells derived from BPH. Treatment of these cells with LSESr significantly altered gene expression patterns as assessed by comparative gene expression profiling on gene chip arrays. The expression changes were manifested three hours following in vitro administration of LSESr, suggesting a rapid action for this compound. Among the genes most consistently affected by LSESr treatment, we found numerous genes that were categorized as part of proliferative, apoptotic, and inflammatory pathways. Validation studies using quantitative real-time PCR confirmed the deregulation of genes known to exhibit key roles in these biological processes including IL1B, IL1A, CXCL6, IL1R1, PTGS2, ALOX5, GAS1, PHLDA1, IL6, IL8, NFkBIZ, NFKB1, TFRC, JUN, CDKN1B, and ERBB3. Subsequent analyses also indicated that LSESr treatment can impede the stimulatory effects of certain proinflammatory cytokines such as IL6, IL17, and IL15 in these cells. These results suggest that LSESr may be useful to treat BPH that manifest inflammation characteristics. This also supports a role for inflammation in BPH presumably by mediating the balance between apoptosis and proliferation.http://www.mdpi.com/1422-0067/14/7/14301benign prostatic hyperplasiainflammationphytotherapySerenoa repensgene expression analysis
collection DOAJ
language English
format Article
sources DOAJ
author Stéphane Terry
Alexandre de la Taille
Aurélien Descazeaud
Francis Vacherot
Virginie Fasolo
Nanor Sirab
Grégoire Robert
spellingShingle Stéphane Terry
Alexandre de la Taille
Aurélien Descazeaud
Francis Vacherot
Virginie Fasolo
Nanor Sirab
Grégoire Robert
Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
International Journal of Molecular Sciences
benign prostatic hyperplasia
inflammation
phytotherapy
Serenoa repens
gene expression analysis
author_facet Stéphane Terry
Alexandre de la Taille
Aurélien Descazeaud
Francis Vacherot
Virginie Fasolo
Nanor Sirab
Grégoire Robert
author_sort Stéphane Terry
title Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
title_short Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
title_full Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
title_fullStr Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
title_full_unstemmed Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
title_sort lipidosterolic extract of serenoa repens modulates the expression of inflammation related-genes in benign prostatic hyperplasia epithelial and stromal cells
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2013-07-01
description Despite the high prevalence of histological Benign Prostatic Hypeplasia (BPH) in elderly men, little is known regarding the molecular mechanisms and networks underlying the development and progression of the disease. Here, we explored the effects of a phytotherapeutic agent, Lipidosterolic extract of the dwarf palm plant Serenoa repens (LSESr), on the mRNA gene expression profiles of two representative models of BPH, BPH1 cell line and primary stromal cells derived from BPH. Treatment of these cells with LSESr significantly altered gene expression patterns as assessed by comparative gene expression profiling on gene chip arrays. The expression changes were manifested three hours following in vitro administration of LSESr, suggesting a rapid action for this compound. Among the genes most consistently affected by LSESr treatment, we found numerous genes that were categorized as part of proliferative, apoptotic, and inflammatory pathways. Validation studies using quantitative real-time PCR confirmed the deregulation of genes known to exhibit key roles in these biological processes including IL1B, IL1A, CXCL6, IL1R1, PTGS2, ALOX5, GAS1, PHLDA1, IL6, IL8, NFkBIZ, NFKB1, TFRC, JUN, CDKN1B, and ERBB3. Subsequent analyses also indicated that LSESr treatment can impede the stimulatory effects of certain proinflammatory cytokines such as IL6, IL17, and IL15 in these cells. These results suggest that LSESr may be useful to treat BPH that manifest inflammation characteristics. This also supports a role for inflammation in BPH presumably by mediating the balance between apoptosis and proliferation.
topic benign prostatic hyperplasia
inflammation
phytotherapy
Serenoa repens
gene expression analysis
url http://www.mdpi.com/1422-0067/14/7/14301
work_keys_str_mv AT stephaneterry lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
AT alexandredelataille lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
AT aureliendescazeaud lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
AT francisvacherot lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
AT virginiefasolo lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
AT nanorsirab lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
AT gregoirerobert lipidosterolicextractofserenoarepensmodulatestheexpressionofinflammationrelatedgenesinbenignprostatichyperplasiaepithelialandstromalcells
_version_ 1724974532522934272